RLMD insider trading
Relmada Therapeutics, Inc.
In the past 36 days, 2 insiders bought $1.7M of Relmada Therapeutics, Inc. stock in 2 open-market purchases. The largest purchase was $844K by Maged Shenouda (Chief Financial Officer) on Sep 9, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
Maged Shenouda Chief Financial Officer |
$844K 200,000 sh @ $4.22 |
+25.0% | Medium
|
Sep 9, 2026 Filed Sep 11, 2026 |
Sergio Traversa Chief Executive Officer |
$828K 200,000 sh @ $4.14 |
+15.4% | Medium
|
Sep 9, 2026 Filed Sep 11, 2026 |
Insider sales
No open-market sales by insiders in this period.